FRESH-PEF156-en
Observational Study on the management of HER2-positive breast cancer with brain metastases and its associated costs
METACOST
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Socio-demographic data']
Individuals
| Topic | Vocabulary |
|---|---|
| Oncology | health theme |
{"level_sex_clusion_I":[{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"• Patients from breast cancer with brain metastase(s) • with overexpressing the HER2 receptor • with brain metastases diagnosed between January 1, 2006 and December 31, 2008","clusion_E":""}
| Name |
|---|
| Christel;LECLERC-ZWIRN |
| Name | Role |
|---|---|
| GLAXOSMITHKLINE (FRANCE) | sponsor |
| Name |
|---|
| GLAXOSMITHKLINE (FRANCE) |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2010-01-01 | 2011-01-01 |
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Christel;LECLERC-ZWIRN | christel.c.leclerc-zwirn@gsk.com |